Sorrento secures Brazil clearance to start Phase IIa long Covid trial
The trial will assess the safety and efficacy of up to three intravenous doses of COVI-MSC administered on alternate days.
South and Central America
Latest in
South and Central America
Resverlogix starts Phase IIb oral Covid-19 drug trial
The trial to assess the efficacy and safety of apabetalone will enrol 100 subjects at centres in Canada and Brazil.
HDT Bio dose first subjects in Phase I Covid-19 vaccine trial
The trial will enrol 90 subjects to assess the safety, tolerability, and immunogenicity of three dose levels of the vaccine.
Eiger obtains DSMB advice to continue Phase III Covid-19 therapy trial
The trial plans to enrol approximately 1,600 Covid-19 patients, with recruitment progressing at 12 trial centres in Brazil.
Middle-income countries’ healthcare sectors to keep rising through to 2024
Healthcare provision markets of middle-income countries are set to climb at an average annual rate of 5.7% in the next…
By
BetterLife begins Phase II inhaled Covid-19 therapy trial in Chile
The trial will enrol 150 subjects with mild or moderate Covid-19, who will be given nebulised AP-003 or placebo.
Asia-Pacific has seen the largest growth in gastrointestinal related trials over the past decade
We've analysed 10 years' worth of clinical trials data from GlobalData to pick out key geographic trends.
By
Africa has seen the largest growth in dermatology-related trials over the past decade
We've analysed 10 years' worth of clinical trials data from GlobalData to pick out key geographic trends.
By